NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: C000000192

Registered date:13/09/2005

Urinary Angiotensinogen as a Marker of Intrarenal Angiotensin II Activity in Patients with Chronic Renal Disease

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedChronic renal diseases
Date of first enrollment2003/02/01
Target sample size80
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeRelationship between urinary angiotensinogen and deterioration of renal function.
Secondary OutcomeEffects of administration of angiotensin receptor blocker on circulating and urinary angiotensinogen levels.

Key inclusion & exclusion criteria

Age minimum16years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaPatients treated with angiotensin converting enzyme inhibitors or angiotensin II receptor blockers

Related Information

Contact

public contact
Name Tatsuo Yamamoto
Address 1-20-1 Handayama, Hamamatsu, Shizuoka 431-3192, Japan Japan
Telephone 053-435-2261
E-mail ytatsuo@hama-med.ac.jp
Affiliation Hamamatsu University School of Medicine First Department of Medicine
scientific contact
Name Tatsuo Yamamoto
Address 1-20-1 Handayama, Hamamatsu, Shizuoka 431-3192, Japan Japan
Telephone 053-435-2261
E-mail
Affiliation Hamamatsu University School of Medicine First Department of Medicine